- Tips for Spending Holiday Time With Family Members Who Live with Dementia
- Tainted Cucumbers Now Linked to 100 Salmonella Cases in 23 States
- Check Your Pantry, Lay’s Classic Potato Chips Recalled Due to Milk Allergy Risk
- Norovirus Sickens Hundreds on Three Cruise Ships: CDC
- Not Just Blabber: What Baby’s First Vocalizations and Coos Can Tell Us
- What’s the Link Between Memory Problems and Sexism?
- Supreme Court to Decide on South Carolina’s Bid to Cut Funding for Planned Parenthood
- Antibiotics Do Not Increase Risks for Cognitive Decline, Dementia in Older Adults, New Data Says
- A New Way to Treat Sjögren’s Disease? Researchers Are Hopeful
- Some Abortion Pill Users Surprised By Pain, Study Says
-
AHA News: Celebrating Pride Month With Mental Health in Mind
TUESDAY, June 6, 2023 (American Heart Association News) — As rainbow flags flutter in the June breeze for Pride Month, many LGBTQ+ people will feel tension in the air. “It’s been a really rough go for LGBTQ...
- Posted June 6, 2023
-
Can Some Cancer Patients Safely Skip Radiation Therapy? New Studies Say Yes
Radiation therapy might not be necessary in treating some forms of rectal cancer and lymphoma, sparing patients from the toxic treatment, a pair of new clinical trials shows. One trial found that rectal cancer patients whose tumors...
- Posted June 6, 2023
-
Money Troubles Can Delay Cancer Diagnoses, Putting Survival in Jeopardy
Money woes have long been linked to worse health care. Now, a new study finds financially strapped patients often put off cancer screenings — only to learn they have the disease when it’s advanced and tougher to...
- Posted June 6, 2023
-
Targeted Drug May Lower Odds for Breast Cancer’s Return in Some Patients
Here’s some good news for women with the most common type of breast cancer: Adding a targeted breast cancer drug to hormonal therapy reduced the risk of cancer returning by 25% for women with early-stage disease, a...
- Posted June 6, 2023
-
Opdivo Could Boost Outcomes for People Battling Hodgkin Lymphoma
The widely used immunotherapy drug nivolumab (Opdivo) is safer and more effective in treating adults and children with advanced Hodgkin lymphoma than the targeted therapy now used as standard care is, new clinical trial results show. Nivolumab...
- Posted June 6, 2023
-
More U.S. Kids, Teens Are Getting Weight-Loss Surgeries
As obesity rises among U.S. kids and teens, the number of weight-loss surgeries is growing, too. Metabolic and bariatric surgeries among 10- to 19-year-olds rose by nearly 20% between 2020 and 2021, after climbing since 2016, a...
- Posted June 6, 2023
-
Could a Nitroglycerin Patch Ease Hot Flashes?
A new study on using nitroglycerin patches to help women with frequent hot flashes caused by menopause has delivered mixed results. The benefits of wearing these patches — long used as chest pain medication — were modest....
- Posted June 6, 2023
-
Another Reason to Hate Mondays: Higher Risk for Severe Heart Attacks
Monday can be a downer as folks leave weekend play behind. Now, researchers say Monday might also be the most common day for deadly heart attacks. Doctors at the Belfast Health and Social Care Trust and the...
- Posted June 6, 2023
-
Chinese Company May Help Ease U.S. Shortage of Cancer Drug
With the United States facing a high number of drug shortages, a Chinese company may help to boost the supply of one in particular, the chemotherapy agent cisplatin. The U.S. Food and Drug Administration is working with...
- Posted June 5, 2023
-
One Form of Menopause Hormone Therapy Might Raise Blood Pressure
Women who use estrogen to ease menopause symptoms may see their blood pressure rise — but the way they take the hormone may determine that, a large new study suggests. The study, of over 100,000 menopausal women...
- Posted June 5, 2023